title: Nuclear cardiology, Part II: Scintigraphic evaluation of cardiac function.
abstract: Different methods are currently available to assess cardiac function, especially left ventricular ejection fraction, using either planar or tomographic imaging, first-pass or equilibrium techniques, and blood-pool or myocardial perfusion agents. This is the second article of a four-part series on nuclear cardiology. In this article the authors review the most widely used radiopharmaceuticals and methodologies.
authors.affiliation: Middelheim Hospital, Antwerp, Belgium.
authors.forename: A S
authors.initials: AS
authors.lastname: Hambÿe
authors.forename: H
authors.initials: H
authors.lastname: Everaert
authors.forename: A
authors.initials: A
authors.lastname: Maes
authors.forename: L
authors.initials: L
authors.lastname: Mesotten
authors.forename: J
authors.initials: J
authors.lastname: Vandevivere
authors.forename: L
authors.initials: L
authors.lastname: Mortelmans
authors.forename: P R
authors.initials: PR
authors.lastname: Franken
mesh_terms: D003326:Coronary Circulation; D015637:Gated Blood-Pool Imaging; D006321:Heart / Q000000981:diagnostic imaging* / Q000502:physiology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D011875:Radionuclide Angiography; D019275:Radiopharmaceuticals; D013318:Stroke Volume / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon; D016277:Ventricular Function, Left / Q000502:physiology; D016278:Ventricular Function, Right / Q000502:physiology; D015646:Ventriculography, First-Pass
chemical_list: D019275:Radiopharmaceuticals